Compagnie Lombard Odier S Cm A Dexcom Inc Transaction History

Compagnie Lombard Odier S Cm A

$6.12 Billion
Q3 2024

A detailed history of Compagnie Lombard Odier S Cm A transactions in Dexcom Inc stock. As of the latest transaction made, Compagnie Lombard Odier S Cm A holds 151,283 shares of DXCM stock, worth $12.1 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

151,283

Previous 155,714 2.85%

Holding current value

$12.1 Million

Previous $17.7 Million 42.57%

% of portfolio

0.17%

Previous 0.31%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$64.0 - $116.06 $283,584 - $514,261	-4,431 Reduced 2.85%	151,283 $10.1 Million
Q2 2024 Jul 18, 2024	BUY	$110.31 - $140.45 $341,850 - $435,254	3,099 Added 2.03%	155,714 $17.7 Million
Q1 2024 May 01, 2024	BUY	$114.22 - $140.1 $2.94 Million - $3.6 Million	25,700 Added 20.25%	152,615 $21.2 Million
Q4 2023 Jan 16, 2024	BUY	$75.49 - $124.16 $1.73 Million - $2.85 Million	22,942 Added 22.07%	126,915 $15.7 Million
Q3 2023 Oct 23, 2023	BUY	$86.06 - $137.93 $6.1 Million - $9.78 Million	70,923 Added 214.59%	103,973 $9.7 Million
Q2 2023 Aug 07, 2023	BUY	$112.47 - $130.98 $2.02 Million - $2.35 Million	17,972 Added 119.19%	33,050 $4.25 Million
Q1 2023 May 01, 2023	BUY	$104.0 - $122.92 $658,632 - $778,452	6,333 Added 72.42%	15,078 $1.75 Million
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $515,743 - $744,484	6,069 Added 226.79%	8,745 $991,000
Q2 2022 Aug 11, 2022	BUY	$67.99 - $132.89 $126,189 - $246,643	1,856 Added 226.34%	2,676 $199,000
Q1 2022 Apr 27, 2022	BUY	$94.08 - $130.2 $51,744 - $71,610	550 Added 203.7%	820 $420,000
Q4 2021 Feb 09, 2022	SELL	$129.87 - $162.82 $32,467 - $40,705	-250 Reduced 48.08%	270 $146,000
Q3 2021 Oct 28, 2021	BUY	$106.71 - $143.18 $26,677 - $35,795	250 Added 92.59%	520 $285,000
Q3 2020 Nov 12, 2020	SELL	$95.51 - $112.95 $7,640 - $9,036	-80 Reduced 22.86%	270 $111,000
Q2 2020 Aug 14, 2020	SELL	$62.68 - $105.34 $9,402 - $15,801	-150 Reduced 30.0%	350 $142,000
Q3 2019 Nov 12, 2019	SELL	$35.53 - $43.8 $7,106 - $8,760	-200 Reduced 28.57%	500 $75,000
Q2 2019 Aug 14, 2019	BUY	$27.84 - $38.92 $5,568 - $7,784	200 Added 40.0%	700 $105,000
Q1 2019 May 13, 2019	SELL	$28.07 - $38.18 $183,156 - $249,124	-6,525 Reduced 92.88%	500 $60,000
Q4 2018 Feb 13, 2019	SELL	$26.99 - $37.37 $12.2 Million - $16.8 Million	-450,771 Reduced 98.47%	7,025 $842,000
Q3 2018 Nov 13, 2018	SELL	$23.35 - $36.72 $3.47 Million - $5.46 Million	-148,738 Reduced 24.52%	457,796 $65.5 Million
Q2 2018 Aug 10, 2018	SELL	$17.54 - $25.22 $2.78 Million - $4 Million	-158,506 Reduced 20.72%	606,534 $57.6 Million
Q1 2018 May 11, 2018	SELL	$13.06 - $18.54 $1.57 Million - $2.23 Million	-120,489 Reduced 13.61%	765,040 $56.7 Million
Q4 2017 Feb 13, 2018	BUY	$11.12 - $15.38 $441,786 - $611,032	39,729 Added 4.7%	885,529 $50.8 Million
Q3 2017 Nov 14, 2017	BUY	$11.36 - $18.98 $632,377 - $1.06 Million	55,667 Added 7.05%	845,800 $41.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	790,133	790,133 $57.8 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

News

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.

Account

Compagnie Lombard Odier S Cm A Dexcom Inc Transaction History